WON TECH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,860 KRW | +6.36% |
|
-4.61% | -15.76% |
| 2023 | WON TECH Co.,Ltd.(KOSDAQ:A336570) added to S&P Global BMI Index | CI |
| 2023 | WON TECH Co.,Ltd. announced that it has received KRW 30 billion in funding | CI |
| Sales 2024 * | 152B 110M | Sales 2025 * | 198B 143M | Capitalization | 702B 507M |
|---|---|---|---|---|---|
| Net income 2024 * | 44B 31.77M | Net income 2025 * | 64B 46.21M | EV / Sales 2024 * | 4.24 x |
| Net cash position 2024 * | 56.06B 40.48M | Net cash position 2025 * | 115B 83.35M | EV / Sales 2025 * | 2.97 x |
| P/E ratio 2024 * |
15.8
x | P/E ratio 2025 * |
10.9
x | Employees | 202 |
| Yield 2024 * |
0.7% | Yield 2025 * |
0.83% | Free-Float | 48.1% |
More Fundamentals
* Assessed data
More news
| 1 day | +6.36% | ||
| 1 week | -4.61% | ||
| 1 month | -23.98% | ||
| 3 months | -6.98% | ||
| 6 months | -25.21% | ||
| Current year | -15.76% |
1 week
7 350.00
8 390.00
1 month
7 350.0011 400.00
Current year
7 350.0012 000.00
1 year
7 350.0015 110.00
3 years
2 090.0015 110.00
5 years
1 970.0015 110.00
10 years
1 970.0015 110.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jung-Hyun Kim
CEO | Chief Executive Officer | 41 | 14-02-28 |
Jong-Won Kim
CEO | Chief Executive Officer | 72 | 03-02-28 |
Young-Sik Suh
CTO | Chief Tech/Sci/R&D Officer | 58 | 08-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jong-Won Kim
CEO | Chief Executive Officer | 72 | 03-02-28 |
Jung-Hyun Kim
CEO | Chief Executive Officer | 41 | 14-02-28 |
Hyeong-Jun Kim
BRD | Director/Board Member | 52 | 20-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 7,860 | +6.36% | 1,780,903 |
| 24-05-30 | 7,390 | -1.99% | 1,017,430 |
| 24-05-29 | 7,540 | -4.19% | 2,977,239 |
| 24-05-28 | 7,870 | -4.26% | 2,367,218 |
| 24-05-27 | 8,220 | -0.24% | 1,052,761 |
End-of-day quote Korea S.E., May 30, 2024
More quotes
Won Tech Co Ltd, formerly Daishin Balance No.8 Special Purpose Acquisition Company, is a Korea-based company engaged in the medical devices. The Company provides products and services.
Calendar
2024-08-04
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7,860
KRW
Average target price
12,875
KRW
Spread / Average Target
+63.80%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.76% | 508M | |
| +75.69% | 12.57B | |
| -24.68% | 7.34B | |
| +6.22% | 6.61B | |
| +12.58% | 5.39B | |
| +26.90% | 4.53B | |
| -21.14% | 3.91B | |
| -22.99% | 2.91B | |
| +47.42% | 2.37B | |
| -0.37% | 2B |
- Stock Market
- Equities
- A336570 Stock
